MedPath

The Case Comprehensive Cancer Center

The Case Comprehensive Cancer Center logo
🇺🇸United States
Ownership
Subsidiary
Established
1826-01-01
Employees
5K
Market Cap
-
Website
http://www.case.edu/cancer

Intra-Osseous Co-Transplant of UCB and hMSC

Early Phase 1
Completed
Conditions
Acute Lymphoblastic Leukemia
Relapsed Chronic Lymphocytic Leukemia
Refractory Chronic Lymphocytic Leukemia
Chronic Myelogenous Leukemia
Acute Myelogenous Leukemia
Myelofibrosis
Relapsed Non-Hodgkin Lymphoma
Hodgkin Lymphoma
Refractory Hodgkin Lymphoma
Lymphoid Malignancies
Interventions
Radiation: total-body irradiation
Procedure: umbilical cord blood transplantation
Procedure: mesenchymal stem cell transplantation
First Posted Date
2014-07-04
Last Posted Date
2020-12-04
Lead Sponsor
Case Comprehensive Cancer Center
Target Recruit Count
6
Registration Number
NCT02181478
Locations
🇺🇸

Case Comprehensive Cancer Center, Cleveland, Ohio, United States

Vigorous or Moderate Exercise in Enhancing Active Surveillance in Patients With Localized Prostate Cancer

Not Applicable
Withdrawn
Conditions
Recurrent Prostate Cancer
Stage IIA Prostate Cancer
Stage IIB Prostate Cancer
Stage I Prostate Cancer
Interventions
Behavioral: vigorous exercise intervention - standard
Behavioral: moderate exercise intervention
Other: questionnaire administration
Other: laboratory biomarker analysis
Behavioral: vigorous exercise intervention - cybercycling
Behavioral: Exercise Logs
Behavioral: Adherence
Behavioral: Exercise and body composition test
First Posted Date
2014-07-02
Last Posted Date
2018-08-09
Lead Sponsor
Case Comprehensive Cancer Center
Registration Number
NCT02179762

Magnetic Resonance Guided Focal Stereotactic Body Radiation Therapy for Localized Prostate Cancer

Not Applicable
Completed
Conditions
Stage I Prostate Cancer
Stage IIB Prostate Cancer
Adenocarcinoma of the Prostate
Recurrent Prostate Cancer
Stage IIA Prostate Cancer
Interventions
Radiation: stereotactic radiosurgery
Device: magnetic resonance imaging
Other: quality-of-life assessment
Procedure: Serum Prostate Antigen Test
Procedure: Digital Rectal Exam
Behavioral: Expanded Prostate Cancer Index Composite
First Posted Date
2014-06-13
Last Posted Date
2024-05-10
Lead Sponsor
Case Comprehensive Cancer Center
Target Recruit Count
12
Registration Number
NCT02163317
Locations
🇺🇸

University Hospitals Cleveland Medical Center, Case Comprehensive Cancer Center, Cleveland, Ohio, United States

Stereotactic Radiosurgery and Metformin in Patients With Borderline-Resectable or Locally-Advanced Pancreatic Cancer

Early Phase 1
Completed
Conditions
Duct Cell Adenocarcinoma of the Pancreas
Stage I-III Pancreatic Cancer
Acinar Cell Adenocarcinoma of the Pancreas
Recurrent Pancreatic Cancer
Interventions
Radiation: stereotactic radiosurgery
First Posted Date
2014-06-03
Last Posted Date
2020-06-26
Lead Sponsor
Case Comprehensive Cancer Center
Target Recruit Count
8
Registration Number
NCT02153450
Locations
🇺🇸

University Hospitals Cleveland Medical Center, Seidman Cancer Center, Case Comprehensive Cancer Center, Cleveland, Ohio, United States

Protein-Sparing Modified Fast Intervention for Weight Loss in Obese Endometrial Cancer Survivors

Not Applicable
Completed
Conditions
Endometrial Cancer
Obesity
Interventions
Dietary Supplement: Dietary Intervention
Other: Informational Material
Other: Dietary Education
Dietary Supplement: Weight Maintenance
Other: Average score of Obesity and Weight-Loss Quality of Life Questionnaire
First Posted Date
2014-05-12
Last Posted Date
2017-09-20
Lead Sponsor
Case Comprehensive Cancer Center
Target Recruit Count
11
Registration Number
NCT02135562
Locations
🇺🇸

MetroHealth Medical Center, Cleveland, Ohio, United States

🇺🇸

Cleveland Medical Center, University Hospitals, Seidman Cancer Center, Case Comprehensive Cancer Center, Cleveland, Ohio, United States

MRI Before Biopsy in Diagnosing Patients With Prostate Cancer

Terminated
Conditions
Prostate Cancer
Interventions
Device: magnetic resonance imaging
Procedure: prostate biopsy
First Posted Date
2014-05-06
Last Posted Date
2017-12-21
Lead Sponsor
Case Comprehensive Cancer Center
Target Recruit Count
139
Registration Number
NCT02131207
Locations
🇺🇸

University Hospitals, Case Comprehensive Cancer Center, Cleveland, Ohio, United States

Web-Based Tailored Educational Program in Improving Nurse Communication With Patients About Clinical Trials

Not Applicable
Completed
Conditions
Healthy, no Evidence of Disease
Interventions
Other: IMPACT intervention
Other: Online education materials
Other: survey administration
First Posted Date
2014-05-02
Last Posted Date
2020-07-21
Lead Sponsor
Case Comprehensive Cancer Center
Target Recruit Count
1262
Registration Number
NCT02129517
Locations
🇺🇸

University Hospitals Cleveland Medical Center, Seidman Cancer Center, Case Comprehensive Cancer Center, Cleveland, Ohio, United States

Low Glycemic Load Diet in Patients With Stage I-III Colon Cancer

Not Applicable
Completed
Conditions
Stage I Colon Cancer
Stage III Colon Cancer
Stage I Rectal Cancer
Stage II Colon Cancer
Stage II Rectal Cancer
Stage III Rectal Cancer
Interventions
Other: questionnaire administration
Behavioral: Standard Dietary Intervention
Other: laboratory biomarker analysis
Behavioral: Low glycemic load
Behavioral: Intensified Dietary Intervention
Behavioral: Medium Glycemic Load
First Posted Date
2014-05-02
Last Posted Date
2018-07-20
Lead Sponsor
Case Comprehensive Cancer Center
Target Recruit Count
18
Registration Number
NCT02129218
Locations
🇺🇸

Case Comprehensive Cancer Center, Cleveland, Ohio, United States

🇺🇸

Metrohealth Medical Center, Cleveland, Ohio, United States

Psychoeducational and Behavioral Strategies in Reducing Distress and Anxiety in Patients With Multiple Myeloma and Their Family Caregivers

Not Applicable
Completed
Conditions
Multiple Myeloma
Interventions
Other: educational intervention
Other: Psychoeducational intervention
Behavioral: behavioral intervention
Other: telephone-based intervention
Other: counseling intervention
Other: questionnaire administration
Other: quality-of-life assessment
First Posted Date
2014-05-02
Last Posted Date
2017-03-20
Lead Sponsor
Case Comprehensive Cancer Center
Target Recruit Count
30
Registration Number
NCT02129569
Locations
🇺🇸

Case Comprehensive Cancer Center, Cleveland, Ohio, United States

Targeted Marrow Irradiation, Fludarabine Phosphate, and Busulfan Before Donor Progenitor Cell Transplant in Treating Patients With Hematologic Malignancies

Phase 1
Completed
Conditions
Acute Myeloid Leukemia
Acute Lymphocytic Leukemia
Myeloproliferative Syndrome
Non Hodgkin Lymphoma
Hodgkin Lymphoma
Myelodysplastic Syndrome
Hematologic Malignancies
Multiple Myeloma
Chronic Lymphocytic Leukemia
Chronic Myeloid Leukemia
Interventions
Radiation: total marrow irradiation
Procedure: myeloid progenitor cell transplantation
Biological: anti-thymocyte globulin
Other: laboratory biomarker analysis
First Posted Date
2014-05-02
Last Posted Date
2021-05-07
Lead Sponsor
Case Comprehensive Cancer Center
Target Recruit Count
14
Registration Number
NCT02129582
Locations
🇺🇸

University Hospitals Cleveland Medical Center, Seidman Cancer Center, Case Comprehensive Cancer Center, Cleveland, Ohio, United States

© Copyright 2025. All Rights Reserved by MedPath